These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Pharmaceuticals: drug importation--2005. End of Year Issue Brief. Varma P; Seay M Issue Brief Health Policy Track Serv; 2005 Dec; ():1-20. PubMed ID: 16708457 [No Abstract] [Full Text] [Related]
23. The impact of FDA reform. Trunzo J Med Device Technol; 2003 Apr; 14(3):36-7. PubMed ID: 12789699 [TBL] [Abstract][Full Text] [Related]
24. Free rein for drug ads? A slowdown in FDA review has left consumers more vulnerable to misleading messages. Consum Rep; 2003 Feb; 68(2):33-7. PubMed ID: 12516586 [No Abstract] [Full Text] [Related]
25. Revisiting Factor VIII cases: is it time for an agency adjudication system? Su YC Food Drug Law J; 2008; 63(4):943-61. PubMed ID: 19601390 [No Abstract] [Full Text] [Related]
26. Mandate safety caps on all drug samples. Prymowicz S Am Pharm; 1989 Jul; NS29(7):4. PubMed ID: 2763977 [No Abstract] [Full Text] [Related]
27. Child-resistant packaging for certain over-the-counter drug products. Final rule. Consumer Product Safety Commission Fed Regist; 2001 Aug; 66(149):40111-6. PubMed ID: 11732555 [TBL] [Abstract][Full Text] [Related]
28. Pharmacy compounding of bioidentical hormone replacement therapy (BHRT): a proposed new approach to justify FDA regulation of these prescription drugs. Patsner B Food Drug Law J; 2008; 63(2):459-91. PubMed ID: 18561473 [No Abstract] [Full Text] [Related]
29. Packaging of pharmaceuticals: still too many dangers but several encouraging initiatives. Prescrire Int; 2007 Jun; 16(89):126-8. PubMed ID: 17585428 [TBL] [Abstract][Full Text] [Related]
30. Anticipating new consumer protection challenges in the food and drug marketplace. Parnes LB Food Drug Law J; 2008; 63(2):593-9. PubMed ID: 18561480 [No Abstract] [Full Text] [Related]
31. Short communication: a study on the packaging information of essential drug products used at Union and Thana health complex level in Bangladesh. Amran S; Ahmed M; Shaheen SM; Morshed SN; Khandakar J; Rahman M; Rahman M; Hossain A Pak J Pharm Sci; 2007 Oct; 20(4):327-32. PubMed ID: 17604258 [TBL] [Abstract][Full Text] [Related]
32. Drugs, codes, standards, and other incompatible things in the dark. Chute CG MD Comput; 2001; 18(1):45-6. PubMed ID: 11236386 [No Abstract] [Full Text] [Related]
33. Safety packaging for dangerous drugs. Freeman A J Am Vet Med Assoc; 1973 Mar; 162(5):328. PubMed ID: 4691369 [No Abstract] [Full Text] [Related]
34. Letter: Proper use of safety closures. Cohen MR J Am Pharm Assoc; 1974 Jan; 14(1):3. PubMed ID: 4809108 [No Abstract] [Full Text] [Related]
35. "Insuring" the continued solvency of pharmaceutical companies in the face of product liability class actions. Chodock R; Yolkut D; Connolly DR Tort Trial Insur Pract Law J; 2005; 40(3):997-1017. PubMed ID: 16100814 [TBL] [Abstract][Full Text] [Related]
36. The Dietary Supplement Health and Education Act. Young AL; Bass IS Food Drug Law J; 1995; 50(2):285-92. PubMed ID: 10342995 [No Abstract] [Full Text] [Related]
38. [Plastic containers: current legislation and dangers for consumers]. Belisario MA; Buonocore V; De Lorenzo F Boll Chim Farm; 1979 Sep; 118(9):523-8. PubMed ID: 555339 [No Abstract] [Full Text] [Related]
40. Information from your family doctor. Avoiding counterfeit drugs. American Academy of Family Physicians Fam Pract Manag; 2007 Mar; 14(3):36. PubMed ID: 17408129 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]